Mixed treatment for same-severe mixed urinary incontinence: A novel method.

Autor: Hamidi Alamdari D; Vascular and Endovascular Surgery Research Center Mashhad University of Medical Sciences Mashhad Iran., Douzandeh A; Department of Health and Biomedicine Victoria University Melbourne Victoria Australia., Keshvari Shirvan M; Department of Urology Imam Reza Academic Hospital, Mashhad University of Medical Sciences Mashhad Iran., Narouie B; Department of Urology Zahedan University of Medical Sciences Zahedan Iran., Radpour N; Urology and Nephrology Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2024 Mar 07; Vol. 12 (3), pp. e8579. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
DOI: 10.1002/ccr3.8579
Abstrakt: Key Clinical Message: Innovative mixed treatment offers hope for persistent mixed urinary incontinence (MUI): PRP-Fibrin Glue-Stem Cell injection, Botox, and TVT in a single session. Successful case study reveals promising outcomes, emphasizing the need for further research.
Abstract: Mixed urinary incontinence is a complaint of stress and urge incontinence which affects patients' quality of life and dramatic changes in patients' physical, mental, and socioeconomic status. The treatment is challenging and depends on the dominance of one of the complaints to the other. The progress in the method of treatment is still under discussion. This study reports treatment of a MUI case in a 56-year-old, with a history of MUI of 7-year duration, which was persistent to pharmacological treatment, pelvic muscle training, biofeedback, and anti-incontinence surgery (Burch Colposuspension). PRP-Fibrin Glue-Stem Cell injection, Botox injection, and TVT were performed in a one surgery session. Patient was discharged with ability to urinate with acceptable amount of post void residue. After 3-month follow-up, patient was completely satisfied and happy. Further research is needed to substantiate the efficacy of these mixed treatments for MUI.
Competing Interests: The authors declare no competing interest regarding the publication of this article.All human subjects provided written informed consent with guarantees of confidentiality. The authors are employed at an academic or research institution where research or education is the primary function of the entity.
(© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje